Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD
Authors
Keywords
-
Journal
NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume 27, Issue 5, Pages 1957-1966
Publisher
Oxford University Press (OUP)
Online
2011-11-22
DOI
10.1093/ndt/gfr609
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Important Differences in Measurement of Fetuin-A
- (2013) Edward R. Smith ANNALS OF INTERNAL MEDICINE
- Runx2-Upregulated Receptor Activator of Nuclear Factor κB Ligand in Calcifying Smooth Muscle Cells Promotes Migration and Osteoclastic Differentiation of Macrophages
- (2011) Chang Hyun Byon et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- An electrochemical impedance spectroscopy (EIS) assay measuring the calcification inhibition capacity in biological fluids
- (2011) A.H. Ismail et al. BIOSENSORS & BIOELECTRONICS
- Fetuin-A Regulation of Calcified Matrix Metabolism
- (2011) Willi Jahnen-Dechent et al. CIRCULATION RESEARCH
- Vascular Calcification in Chronic Renal Failure
- (2011) Ellen Neven et al. CIRCULATION RESEARCH
- Increased serum phosphate and adverse clinical outcomes: unraveling mechanisms of disease
- (2011) Orlando M Gutiérrez CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- FGF-23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4. Another link between chronic kidney disease-mineral bone disorder and the heart
- (2011) M. L. Ford et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Bone morphogenetic protein-2 may represent the molecular link between oxidative stress and vascular stiffness in chronic kidney disease
- (2010) G. Dalfino et al. ATHEROSCLEROSIS
- Fetuin-A Is a Mineral Carrier Protein: Small Angle Neutron Scattering Provides New Insight on Fetuin-A Controlled Calcification Inhibition
- (2010) Alexander Heiss et al. BIOPHYSICAL JOURNAL
- Inhibition of Bone Morphogenetic Proteins Protects Against Atherosclerosis and Vascular Calcification
- (2010) Yucheng Yao et al. CIRCULATION RESEARCH
- Poor agreement between commercial ELISAs for plasma fetuin-A: An effect of protein glycosylation?
- (2010) Edward R. Smith et al. CLINICA CHIMICA ACTA
- Inflammation and the Osteogenic Regulation of Vascular Calcification
- (2010) Jian-Su Shao et al. HYPERTENSION
- Aortic Stiffness Is Independently Associated With Rate of Renal Function Decline in Chronic Kidney Disease Stages 3 and 4
- (2010) Martin L. Ford et al. HYPERTENSION
- Oxidized low-density lipoprotein promotes osteoblast differentiation in primary cultures of vascular smooth muscle cells by up-regulatingOsterixexpression in an Msx2-dependent manner
- (2010) Jesse Taylor et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Fetuin-Mineral Complex Reflects Extraosseous Calcification Stress in CKD
- (2010) T. Hamano et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro
- (2010) Andrew P. Sage et al. KIDNEY INTERNATIONAL
- Fetuin-A is an independent determinant of change of aortic stiffness over 1 year in non-diabetic patients with CKD stages 3 and 4
- (2010) M. L. Ford et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Tumor necrosis factor-α increases alkaline phosphatase expression in vascular smooth muscle cells via MSX2 induction
- (2009) Hye-Lim Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A Shielding Topology Stabilizes the Early Stage Protein-Mineral Complexes of Fetuin-A and Calcium Phosphate: A Time-Resolved Small-Angle X-ray Study
- (2009) Christophe N. Rochette et al. CHEMBIOCHEM
- Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
- (2009) Orlando M. Gutiérrez et al. CIRCULATION
- Mineral Metabolism and Inflammation in Chronic Kidney Disease Patients: A Cross-Sectional Study
- (2009) J. F. Navarro-Gonzalez et al. Clinical Journal of the American Society of Nephrology
- Associations between vascular calcification, arterial stiffness and bone mineral density in chronic hemodialysis patients
- (2009) Akiko Aoki et al. Geriatrics & Gerontology International
- Mineralization by Inhibitor Exclusion
- (2009) Paul A. Price et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- An Initial Characterization of the Serum Phosphoproteome
- (2009) Weidong Zhou et al. JOURNAL OF PROTEOME RESEARCH
- Fetuin-A Protects against Atherosclerotic Calcification in CKD
- (2009) R. Westenfeld et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The emerging role of phosphate in vascular calcification
- (2009) Cecilia M. Giachelli KIDNEY INTERNATIONAL
- Fully phosphorylated fetuin-A forms a mineral complex in the serum of rats with adenine-induced renal failure
- (2009) Isao Matsui et al. KIDNEY INTERNATIONAL
- BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells
- (2008) Xianwu Li et al. ATHEROSCLEROSIS
- Hierarchical Role of Fetuin-A and Acidic Serum Proteins in the Formation and Stabilization of Calcium Phosphate Particles
- (2008) Alexander Heiss et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Oxidized low-density lipoprotein acts synergistically with β-glycerophosphate to induce osteoblast differentiation in primary cultures of vascular smooth muscle cells
- (2008) Mackenzie Bear et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Effect of particle size on hydroxyapatite crystal-induced tumor necrosis factor alpha secretion by macrophages
- (2007) Imad Nadra et al. ATHEROSCLEROSIS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started